Overexpression of SMYD2 contributes to malignant outcome in gastric cancer

BACKGROUND: SET and MYND domain-containing protein 2 (SMYD2) is a lysine methyltransferase for histone H3, p53 and Rb and inhibits their transactivation activities. In this study, we tested whether SMYD2 (1q42) acts as a cancer-promoting factor by being overexpressed in gastric cancer. METHODS: We a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: Komatsu, S, Ichikawa, D, Hirajima, S, Nagata, H, Nishimura, Y, Kawaguchi, T, Miyamae, M, Okajima, W, Ohashi, T, Konishi, H, Shiozaki, A, Fujiwara, H, Okamoto, K, Tsuda, H, Imoto, I, Inazawa, J, Otsuji, E
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2015
Assuntos:
Molecular Diagnostics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4453442/
https://ncbi.nlm.nih.gov/pubmed/25321194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.543
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados